Roche Diagnostics launches Cobas 6800 for SARS COV-2 diagnostic testing in India
- by Team ABLE - 30 Jul, 2020
Roche Diagnostics India has announced the launch of its first Cobas 8800 instrument at National Institute of Cholera and Enteric Diseases, Kolkata also known as ICMR-NICED.
Roche has said that the Cobas 6800 was launched at National Institute for Research in Reproductive Health, Mumbai also known as ICMR- NIRRH to aid with SARS CoV-2 diagnostic testing.
Operating on the real-time reverse transcription polymerase chain reaction (RT-PCR) platform, SARS-CoV-2 diagnostic tests on the instrument detects the genetic signature (RNA) of the virus in a simple test performed by a healthcare provider using nasopharyngeal and oropharyngeal swab samples.
The globally widely available Roche's Cobas 6800/8800 systems provides test results in three and half hours and offer improved operating efficiency, flexibility and fastest time-to-results with the highest throughput providing up to 96 results in about three hours and a total of 384 results for the cobas 6800 System and 960 results for the cobas 8800 System in 8 hours.
The test can be run simultaneously with other diagnostic assays provided by Roche Diagnostics, including HIV and Hepatitis.
Cobas 6800 was launched at National Institute for Research in Reproductive Health, Mumbai also known as ICMR- NIRRH to aid with SARS CoV-2 diagnostic testing.